Sleep Problems, Substance Use Disorders, and Neuropharmacology

Sleep Disorders and Hypocretin Neurochemistry

  • Narcolepsy Pathophysiology: Linked to reduced hypocretin (orexin) levels in specific brain areas. Modern therapeutics target hypocretin receptors rather than traditional stimulant mechanisms.

  • Clinical Presentation (McCarty, 2010): A 5050-year-old woman presented with excessive daytime sleepiness and unusual unilateral cataplexy on her right side. Combined therapy of a traditional stimulant and an antidepressant achieved dramatic improvement after stimulant monotherapy failed.

Diagnostic Framework for Substance Use Disorders

  • DSM-5 Definition: Compulsive pattern of drug consumption despite adverse consequences, driven by physical and psychological dependence.

  • Core Components:

    • Physical Dependence: Physiological adaptation resulting in withdrawal symptoms upon drug cessation.

    • Psychological Dependence: Emotional craving or compulsion to relieve distress; essential for DSM-5 diagnosis.

    • Tolerance: Escalating dose requirement to achieve initial drug effects, heightening overdose risk.

    • Diagnostic Limits: Physical dependence alone occurs with non-abused therapeutic drugs and is insufficient for diagnosing a substance use disorder without compulsive abuse and craving.

Drug Withdrawal and Neuropharmacology

  • Withdrawal Dynamics: Symptoms typically mirror the opposite of the drug's primary effects (e.g., sedative withdrawal causes agitation and hyper-arousal).

  • Mechanism of Action:

    • Agonists: Facilitate or enhance specific endogenous neurotransmitter system activity.

    • Antagonists: Block or decrease neurotransmitter system activity.

CNS Depressants and the GABA System

  • Depressant Classes: Ethanol, barbiturates, and benzodiazepines act as agonists for the extGABAext{GABA} neurotransmitter system, producing inhibitory and sedative effects.

  • Cellular Mechanism: Binding to dedicated receptor sites on the extGABAext{GABA}-gated chloride (extCl−ext{Cl}^-) channel triggers an influx of extCl−ext{Cl}^- ions, inducing neuronal hyperpolarization and suppressing action potentials.

  • Alcohol Impact & Risks: Ranges from mild disinhibition at low doses to sedation, blackouts, and loss of consciousness at high doses. Associated with Fetal Alcohol Spectrum Disorder (FASD) and severe, potentially life-threatening withdrawal requiring direct medical supervision.